Acadia Pharmaceuticals buy Citigroup Inc.
Start price
07.08.25
/
50%
€20.40
Target price
07.08.26
-
Performance (%)
-11.74%
Price
20.05.26
€18.01
Summary
This prediction is currently active. The price of Acadia Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.74%. This prediction currently runs until 07.08.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | -2.676% | -2.676% |
| iShares Core DAX® | 1.119% | -1.545% |
| iShares Nasdaq 100 | 0.352% | 9.674% |
| iShares Nikkei 225® | -1.414% | 2.906% |
| iShares S&P 500 | 0.537% | 4.775% |
Comments by Citigroup_Inc_ for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "outperform" rating re-affirmed by analysts at Citigroup Inc..
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€18.83
08.05.26
08.05.26
€27.29
08.05.27
08.05.27
-6.29%
20.05.26
20.05.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.56
08.08.24
08.08.24
€21.06
08.08.25
08.08.25
43.94%
09.08.25
09.08.25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.59
09.05.24
09.05.24
€27.83
09.05.25
09.05.25
8.26%
10.05.25
10.05.25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.00
13.12.23
13.12.23
€35.17
13.12.24
13.12.24
-17.60%
14.12.24
14.12.24

